Solutions
SOLUTIONS
INSIGHTS
NEWS AND EVENTS
Colleagues across Global Markets recently raised USD$536k during the third annual Commissions for Cancer event. This year marked an expansion with colleagues from US Equities joining those from Rates, FX, and Futures, resulting in a remarkable 34% donation increase compared to the previous year.
Throughout the five-day event, clients continued algorithmic trading, with a portion of net commissions donated to the Leukemia & Lymphoma Society (LLS) to help further the important work of the cancer research organisation. Barclays started Commissions for Cancer three years ago and has since raised over $1mn for LLS.
"Once again, this event has exceeded all our expectations. Hearing from clients how pleased they were to support us during this event and actively channeling their flow to us is truly the culmination of why this event is so successful and will continue to succeed for years to come."
LLS is the largest nonprofit dedicated to curing blood cancer. The organisation has invested nearly $1.3bn into groundbreaking research, much of it focused on pediatric treatments.
Barclays has supported LLS since 2009, raising over $8.5mn for the nonprofit's cancer research initiatives. As one of the nonprofit's top U.S. partners, Barclays was also the first to raise more than $1mn for the LLS Light the Night Walk.
* We acknowledge and agree for Barclays to collect, use and otherwise process our/the Relevant Individual's Information in accordance with the Notice, other effective privacy terms and information processing terms agreed by ourselves/the Relevant Individual with Barclays, for the purposes set out therein, respectively.
* We acknowledge and agree that Barclays may disclose to any third party described in the Notice as a potential recipient of data outside mainland China our.the Relevant Individual's Information in accordance with the Notice, other effective privacy terms and personal information processing terms agreed by ourselves/the Relevant Individual with Barclays, and for the purposes set out therein, respectively.
I consent to my email address being used by Barclays to provide me with personalized advertisements on third-party websites and social media platforms, as described in our Privacy Notice.
An email was sent to you at the address provided. Complete your subscription by clicking the link provided to verify your email address.
Sorry there was a problem. Unfortunately your subscription to our newsletter has encountered an error.
In addition to the cookies we use on our website, we also use cookies and similar technologies in some emails and push notifications. These help us to understand whether you have opened the email and how you have interacted with it. If you have enabled images, cookies may be set on your computer or mobile device. Cookies will also be set if you click on any link within the email.
Please review and manage your email cookie settings below. For more information, please read our Cookie Policy. Please select 'Save and Subscribe' below to remember your email cookie preferences and subscribe to the newsletter.